144 related articles for article (PubMed ID: 3393555)
1. Neoadjuvant chemotherapy in T3-4 N0-X M0 transitional cell carcinoma of the bladder. Problems of clinical and pathological evaluation of response.
Splinter TA; ten Kate FJ; Schröder FH; Denis L; Newling D; Jones WG; Jacqmin D; Boeken Kruger CG; Stoter G; de Voogt HJ
Prog Clin Biol Res; 1988; 269():579-90. PubMed ID: 3393555
[No Abstract] [Full Text] [Related]
2. Preoperative chemotherapy in T3-T4 Nx Mo bladder cancer with cisplatinum and methotrexate.
Denis L; Da Silva FC; Hendrickx L
Prog Clin Biol Res; 1988; 260():571-7. PubMed ID: 3362906
[No Abstract] [Full Text] [Related]
3. [Neoadjuvant chemotherapy using cisplatin (CDDP) and methotrexate (MTX) in carcinoma of the bladder].
Rocco F; Scardino E; Strada G; Franchini V; Larcher P; Favini P; Baccalin A; Giuberti A; Criscpino S; Tancini G
Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):249-55. PubMed ID: 2142809
[TBL] [Abstract][Full Text] [Related]
4. Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy.
Sternberg CN; Yagoda A; Scher HI; Whitmore WF; Herr HW; Morse MJ; Sogani PC; Bosl G; Watson RC; Hollander PS
Prog Clin Biol Res; 1988; 260():551-5. PubMed ID: 3283770
[No Abstract] [Full Text] [Related]
5. The cisplatin-methotrexate neo-adjuvant protocol as first-line therapy of bladder cancer. Present experience in Palermo.
Ingargiola GB; Lamartina M; Cassata G; Corselli G; Serretta V; Caramia G; Rizzo FP; Pavone-Maculuso M
Prog Clin Biol Res; 1988; 260():579-83. PubMed ID: 3362907
[No Abstract] [Full Text] [Related]
6. Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.
Fair WR; Scher H; Herr H; Morse M; Sogani P; Bosi G; Dershaw D; Reuter V; Curley T
Semin Urol; 1990 Aug; 8(3):190-6. PubMed ID: 2399387
[No Abstract] [Full Text] [Related]
7. Pre-cystectomy chemotherapy with sequentially administered cisplatin, cyclophosphamide and adriamycin in invasive transitional cell carcinoma of the bladder (preliminary report).
Guazzieri S; Sperandio P; Fandella A; Garbeglio A; Pegoraro V; Chiarion V; Fiorentino M; Pagano F
Prog Clin Biol Res; 1988; 260():599-602. PubMed ID: 3362909
[No Abstract] [Full Text] [Related]
8. Chemotherapy for advanced urothelial cancer.
Yagoda A
Semin Urol; 1983 Feb; 1(1):60-74. PubMed ID: 6382528
[No Abstract] [Full Text] [Related]
9. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
Walther PJ
Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
[No Abstract] [Full Text] [Related]
10. Pre surgery chemotherapy in bladder cancer.
Francini M; Veronesi A; Dal Bo V; Carbone A; Monfardini S
Prog Clin Biol Res; 1988; 260():585-9. PubMed ID: 3362908
[No Abstract] [Full Text] [Related]
11. [Clinical study of neoadjuvant intraarterial chemotherapy (I A-MAC) for advanced bladder cancer].
Takahashi Y; Deguchi T; Kuriyama M; Nakano M; Ueno K; Shinoda I; Takeda A; Itoh S; Doi T; Takeuchi T
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2311-4. PubMed ID: 7944467
[TBL] [Abstract][Full Text] [Related]
12. [Systemic chemotherapy in advanced bladder cancer. New aspects].
Jakse G
Wien Klin Wochenschr; 1987 Jan; 99(2):54-7. PubMed ID: 3564487
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for metastatic bladder cancer; the EORTC experience.
Stoter G
Prog Clin Biol Res; 1988; 260():471-9. PubMed ID: 3283767
[No Abstract] [Full Text] [Related]
14. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
Koch MO; Coussens D
Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
[No Abstract] [Full Text] [Related]
15. [Is neoadjuvant chemotherapy valid in invasive cancer of the bladder?].
Matveev BP; Figurin KM
Urol Nefrol (Mosk); 1998; (6):42-5. PubMed ID: 10051828
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy for non-organ confined bladder transitional cell carcinoma.
Abi-Aad AS
Acta Urol Belg; 1996 May; 64(2):35-7. PubMed ID: 8701808
[No Abstract] [Full Text] [Related]
17. [Aggressive preoperative chemotherapy in infiltrating bladder carcinoma with a combination of cisplatin, cyclophosphamide and adriamycin. Preliminary report].
Martínez-Piñeiro JA; de la Peña JJ; Hidalgo L; Cisneros J; Jiménez de León J; Machuca J
Arch Esp Urol; 1986; 39(1):33-46. PubMed ID: 3707210
[No Abstract] [Full Text] [Related]
18. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
19. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
Angulo JC; Sanchez-Chapado M; Lopez JI; Flores N
J Urol; 1996 Jun; 155(6):1897-902. PubMed ID: 8618282
[TBL] [Abstract][Full Text] [Related]
20. [MEC treatment (methotrexate, etoposide, cisplatin) for urothelial cancer].
Miura T; Murai T; Shimura H; Kondo I
Gan To Kagaku Ryoho; 1992 May; 19(5):731-3. PubMed ID: 1580650
[No Abstract] [Full Text] [Related]
[Next] [New Search]
